Lymph-node metastases in patients with melanoma: what is the optimum management?

The Lancet Oncology
K Fife, J F Thompson

Abstract

Lymph-node metastasis is an indicator of poor prognosis for patients with melanoma. The management of regional nodes is controversial, with continuing debate about whether surgery or radiotherapy of positive lymph nodes improves long-term survival or whether nodal involvement is merely a marker of aggressive disease. However, there is general agreement that systemic chemotherapy is rarely an effective form of management. This review therefore considers surgical and radiotherapeutic aspects of lymph-node management in patients with melanoma. We discuss regional control and survival after lymph-node surgery in retrospective series, randomised trials of elective lymph-node dissection, the role of 'sentinel' lymph-node biopsy, radiobiology and radiotherapy fractionation issues in melanoma treatment, retrospective studies of adjuvant nodal radiotherapy, and finally, randomised trials of adjuvant radiotherapy after lymph-node dissection.

References

Oct 11, 1992·Surgical Oncology·E J MillerD Guerry
Apr 1, 1992·Archives of Surgery·D L MortonA J Cochran
Mar 1, 1992·World Journal of Surgery·W H McCarthyF Belli
Mar 1, 1992·World Journal of Surgery·C J O'BrienM J Morgan
Sep 1, 1991·American Journal of Surgery·C P KarakousisD L Driscoll
Oct 1, 1991·American Journal of Surgery·C J O'BrienW H McCarthy
Mar 1, 1991·International Journal of Radiation Oncology, Biology, Physics·W T SauseJ Lipsett
Apr 1, 1991·International Journal of Radiation Oncology, Biology, Physics·K R Trott
Nov 1, 1986·The British Journal of Surgery·W G BowsherL E Hughes
Oct 1, 1971·The British Journal of Radiology·D L Dewey
Jan 15, 1983·Cancer·C R JohansonI Quirt
May 1, 1995·World Journal of Surgery·B H BurmeisterC Thorpe
Nov 15, 1994·International Journal of Radiation Oncology, Biology, Physics·K K AngR M Byers
Dec 11, 1997·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·O E NiewegB B Kroon
Jul 27, 1999·International Journal of Radiation Oncology, Biology, Physics·J CorryJ Ainslie
Aug 7, 1999·Journal of the American College of Surgeons·J F ThompsonR B Howman-Giles
Feb 8, 2000·International Journal of Radiation Oncology, Biology, Physics·R J LeeW G Kraybill
Jun 30, 2000·BMJ : British Medical Journal·J M Thomas, E J Patocskai
Jul 6, 2000·Journal of the European Academy of Dermatology and Venereology : JEADV·G LandiA Erbazzi
Apr 21, 2001·Annals of Surgical Oncology·K M McMastersM J Edwards
Dec 18, 2001·Plastic and Reconstructive Surgery·P Tulley, P E Butler
Apr 6, 2004·Facial Plastic Surgery Clinics of North America·Pond Kelemen

❮ Previous
Next ❯

Citations

Feb 22, 2005·Lancet·John F ThompsonRichard F Kefford
Feb 26, 2005·Plastic and Reconstructive Surgery·Hui Q JiangJie S Li
Jul 26, 2006·Annals of Surgical Oncology·Simone MocellinCarlo Riccardo Rossi
Apr 20, 2010·Journal of the American Academy of Dermatology·William G StebbinsArthur J Sober
Dec 5, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H P A M PoosH J Hoekstra
Jan 12, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·S A KoopalH J Hoekstra
Jul 4, 2006·The Lancet Oncology·Graham Stevens, Michael J McKay
Dec 31, 2005·Journal of the American Academy of Dermatology·Timothy M JohnsonMichael S Sabel
May 8, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gemma M RyanChristopher J H Porter
Mar 19, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lisa M KaminskasChristopher J H Porter
Jun 29, 2004·Journal of Surgical Oncology·Lloyd A Mack, J Gregory McKinnon
Oct 28, 2019·Journal of Surgical Oncology·Margot Den HondtSydney Ch'ng
Mar 6, 2018·Expert Opinion on Drug Delivery·Antonella ObinuPaolo Giunchedi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.